CYP17 encodes the enzyme cytochrome P-450c17β£, which mediates both 17β£-hydroxylase and 17,20-lyase in the steroid biosynthesis pathway. A polymorphism in the 5 promoter region of the CYP17 gene has been described. Steroid hormones, especially androgens, are believed to play a key role in the etiolog
Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk
β Scribed by Bao-li Chang; Siqun L. Zheng; Sarah D. Isaacs; Aubrey Turner; Gregory A. Hawkins; Kathy E. Wiley; Eugene R. Bleecker; Patrick C. Walsh; Deborah A. Meyers; William B. Isaacs; Jianfeng Xu
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- French
- Weight
- 72 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
CYP1A1 is likely to play an important role in the etiology of CaP through its function in activating environmental procarcinogens and catalyzing the oxidative metabolites of estrogens. To test the hypothesis that genetic polymorphisms in the CYP1A1 gene may be associated with the risk for CaP, we compared the allele, genotype and haplotype frequencies of 3 SNPs (3801T>C, 2455A>G and 2453C>A) of CYP1A1 among 159 HPC probands, 245 sporadic CaP cases and 222 unaffected men. Two SNPs (3801T>C and 2455A>G) were each individually associated with CaP risk when the allele and genotype frequencies were compared between CaP patients and unaffected controls. Furthermore, a combined SNP analysis using a haplotype approach revealed an even stronger association in Caucasians. Specifically, 4 major haplotypes (TβAβC, CβAβC, CβGβC and TβAβA) accounted for 99.8% of all observed haplotypes. These 4 haplotypes correspond to the previously described nomenclature (CYP1A1*1A, CYP1A1*2A, CYP1A1*2B and CYP1A1*4). The frequencies of these 4 haplotypes were significantly different among CaP patients and controls. The haplotype TβAβC (CYP1A1*1A) was significantly associated with increased risk for CaP, and the haplotype CβAβC (CYP1A1*2A) was significantly associated with decreased risk for CaP. These findings suggest that genetic polymorphisms in CYP1A1 may modify the risk for CaP. Β© 2003 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract It is widely recognized that androgen biosynthesis and metabolism are associated with the development and progression of prostate cancer. The human CYP11A1 gene (__CYP11A1__) encodes the P450scc enzyme, which mediates the first step in sex steroid hormone synthesis. The gene contains a
## Abstract A high fat intake has been associated with prostate cancer risk, and gene polymorphisms of lipoprotein lipase (LPL) play an important role in plasma lipoprotein metabolism. We herein analyzed the association of __LPL__ gene polymorphisms with the risk of prostate cancer in a Japanese po
## Abstract __CCND1__ mRNA is alternatively spliced to produce 2 transcripts, and the splicing pattern may be modulated by a frequent __A__870__G__ singleβnucleotide polymorphism within the conserved splice donor site of exon 4. Several studies have suggested a significant association between the _
## Abstract Lung cancer is one of the leading causes of cancer death worldwide. Tobacco smoking is the main risk factor for lung cancer. Less than 20% of smokers develop lung cancer in their lifetime, however, indicating individual variations in lung cancer risk. Proβinflammatory cytokines produced
## Abstract ## BACKGROUND. In estrogen biosynthetic pathways, many enzymes are important for metabolism, detoxification, and bioavailability. Polymorphisms in these genes may have an effect on the enzymes' function. For example, higher expression and activation of biosynthetic enzymes and lower ex